期刊文献+

普罗布考抑制氧化低密度脂蛋白诱导的人肾近曲小管上皮细胞转分化的作用及机制研究 被引量:2

Inhibitory effects of probucol on the transition of human renal proximal tubular epithelial cells induced by Ox-LDL and exploration of its related mechanisms
下载PDF
导出
摘要 目的研究普罗布考对氧化低密度脂蛋白(oxidized low-density lipoprotein,Ox-LDL)诱导的人肾近曲小管上皮细胞HK-2转分化的保护作用,并探讨凝集素样氧化低密度脂蛋白受体1(lectin-like oxidized low-density lipoprotein receptor-1,LOX-1)及氧化应激在其中的作用和相互关系。方法采用不同浓度Ox-LDL(0-100ug/ml)孵育HK-2细胞,并予普罗布考(20umol/L)和LOX-1抑制剂多聚肌苷酸(250ug/m1)干预。采用四甲基偶氮唑盐微量酶反应比色法检测细胞增殖情况,用DCFH—DA法检测活性氧(reactive oxygen species,ROS)活性,生化比色法检测一氧化氮(nitric oxide,N0)浓度,Western blot检测E-钙粘素(cadherin)、a平滑肌动蛋白(a-smooth muscle actin,a-SMA)、LOX-1、还原型烟酰胺腺嘌呤二核苷酸磷酸(Nicotinamide adenine dinucleotide 2'-phosphate reduced tetrasodium salt,NADPH)氧化酶4(NOX4)表达。结果12.5~200ug/ml浓度范围内的Ox-LDL对HK-2细胞的增殖无明显影响,25-100ug/ml的Ox-LDL以浓度依赖方式促进HK-2细胞LOX-1、a-SMA蛋白表达上升,E-cadherin下降。而多聚肌苷酸、普罗布考能使LOX-1、a-SMA蛋白表达抑制,E-cadherin表达上调。50ug/ml的Ox-LDL能促进NOX4表达上调,ROS活性增加(451.5ug/ml kg839.8ug/ml,P〈0.05),NO含量略增加(46.0umol/L比46.2umol/L),但无统计学意义(P〉0.05)。而多聚肌苷酸、普罗布考能使NOX4表达下调,ROS活性下降,但对NO浓度无明显影响。结论Ox-LDL可诱导HK-2细胞转分化,其机制可能与其结合LOX-1促进氧化应激有关,而普罗布考可以通过降低LOX-1,抑制氧化应激损伤,从而延缓HK-2细胞转分化的进程。 Objective To study the inhibitory effects of probueol on the transition of human renal proximal tubular epithelial cells (HK-2) induced by oxidized low-density lipoprotein (Ox-LDL), and to explore the role and interrelation of lectiwlike oxidized low-density lipoprotein receptor-1 (LOX-1) and oxidative stress. Methods HK-2 cells were cultured and pretreated by different dosages of Ox-LDL (0-100ug/ml) in vitro with probucol (20 umol/L) and LOX-1 inhibitor polyinosinic acid (250ug/ml). Cell proliferation was measured using MTT assay. Activity of reactive oxygen species (ROS) was evaluated using DCFH-DA method. Concentration of nitric oxide (NO) was determined u- sing biochemical colorimetric method. The expression levels of protein E-cadherin, a-SMA, LOX-1 and NADPH oxidase 4 (NOX-4) were examined using Western blotting. Results There was no significant influence of Ox-LDL (12. 5-200 ug/ml) on the proliferation of HK-2 cells, however, OxLDL (25-100 ug/ml) could induce the expression of LOX-1 and a-SMA proteins, while E-cadherin declined simultaneously in a dose-dependent manner. Polyinosinic acid and probucol could inhibit the expression of LOX-1 protein as well as a-SMA protein, while the expression of E-cadherin increased. 50 ug/mL Ox-LDL could induce the expression of NOX4 protein as well as intracellular ROS activity (451.5ug/ml vs. 839. ug/ml, P〈0. 05), while the concentration of cell supernatant NO increased slightly with no significant influence (46 umol/L vs 46. umol/L). However, the increases of NOX4 protein and ROS activity were inhibited by polyinosinic acid and probucol, while the concentration of NO barely changed. Conclusions Ox-LDL could induce the transition of human renal proximal tubular epithelial cells probably through the oxidative stress by the receptor LOX-1. However, probucol and the LOX-1 inhibitor polyinosinic acid could inhibit the injury of oxidative stress by reducing the expression of LOX-1, and delay the process of epithelial to mesenchymal transition.
出处 《临床肾脏病杂志》 2015年第10期620-625,共6页 Journal Of Clinical Nephrology
基金 国家自然科学基金项目(NO.81473480) 上海中医药大学附属普陀医院重点课题(NO.2011Z056) 上海中医药大学第五批后备业务专家培养计划(NO.B-X-78)
关键词 肾小管上皮细胞-肌成纤维细胞转分化 人肾近曲小管上皮细胞 氧化低密度脂蛋白 凝集素样氧化低密度脂蛋白受体1 活性氧 Epithelial to mesenchymal transition Human renal proximal tubular epithelial cells Oxidized high-density lipoprotein Lectin-like oxidized low-density lipoprotein receptor-1 Reactive oxygen species
  • 相关文献

参考文献21

  • 1Porubsky S, Schmid H, Bonrouhi M, et al. Influence of native and hypoehlorite-modified low-density lipoprotein on gene ex- pression in human proximal tubular epithelium[J].Am J Pathol, 2004, 164(6): 2175-2187.
  • 2Khwaja A, E1 Kossi M, Floege J, et al. The management of CKD: a look into the future[J].Kidney international, 2007, 72(11): 1316-1323.
  • 3Klahr S, Morrissey J, Hruska K, et al. New approaches to delay the progression of chronic renal failure[J].Kidney Int Suppl, 2002, 61(80): 23-26.
  • 4Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics[J]. Kidney Int, 2006, 69(2): 213-217.
  • 5Zeisberg M, Kalluri R. The role of epithelial-to-mesenchyrnal transition in renal fibrosis[J]. J Mol Med, 2004, 82(3) : 175-181.
  • 6Allison SJ. Fibrosis: targeting EMT to reverse renal fibrosis [J]. Nat Rev Nephrol, doi: 10. 1038/nrneph, 2015. 133. [pub ahead of print].
  • 7Sawamura T, Kume N, Aoyama T, et al. An endothelial re- ceptor for oxidized low-density lipoprotein[J]. Nature, 1997, 386(6620) : 73-77.
  • 8Hu C, Kang BY, Megyesi J, et al. Deletion of LOX-1 attenu- ates renal injury following angiotensin II infusion[J]. Kidney Int, 2009, 76(5): 521-527.
  • 9Kelly KJ, Wu P, Patterson CE, et al. LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes[J]. Am J Physiol Renal Physiol, 2008, 294(5): F1136-Fl145.
  • 10Dominguez JH, Mehta JL, Li D, et al. Anti-LOX-1 therapy in rats with diabetes and dyslipidemia., ablation of renal vascular and epithelial manifestations[J]. Am J Physiol Renal Physiol, 2008, 294(1) : F110-F119.

二级参考文献22

  • 1Wild S,Roglic G, Green A, et al. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care, 2004,27: 1047-1053.
  • 2RamasamyR, GoldbergIJ. Aldose Reductase and Cardiovascular Diseases, Creating Human-Like Diabetic Complications in an Experimental Model. Circ Res, 2010,106:1449-1458.
  • 3Yan SF, Ramasamy R, Schmidt AM. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med, 2009,87: 235-247.
  • 4Philip W. Connelly. Increased serum advanced glycation end prod- ucts are associated with impairment in HDL antioxidative capacity in diabetic nephropathy, Nephrol. Dial. Transplant, 2008,23:2699-2700.
  • 5Puddu A, Viviani GL. Advancde glycation endproducts and diabetes. Beyond vascular complications. Endocr Metab Immune Disord Drug Targets, 2011,11: 132-140.
  • 6Tang SC,Chan LY, Leung JC, et al. Differential effects of advanced glycation end products on renal tubular cell inflammation. Nephrology, 2011,16: 417-425.
  • 7Josephine M, Forbes ME. Cooper. Glyeation in diabetic nephropathy. Amino Acids, 2010,26 : 771-778.
  • 8Doi K. Noiri E. Fujita T. Role of vascular endothelial growth factor in kidney disease. Curr Vasc Pharmacol, 2010,8 : 122-128.
  • 9Ziyadeh FN. Different roles for TGF-β and VEGF in the pathogenesis of the cardinal features of diabetic nephropathy. Diabetes research, 2008,82 : S38-S41.
  • 10Bondeva T, Wojciech S,Wolf G. Advanced glycation end products inhibit adhesion ability of differentiated podocytes in a neuropilin 1-dependent manner. Am J Physiol Renal Physiol, 2011,301 : 852- 870.

共引文献2

同被引文献19

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部